Close Menu

MDxHealth

This story has been updated to reflect that MDxHealth completed its private placement on June 29.
NEW YORK (GenomeWeb News) – MDxHealth has successfully completed a private placement that raised €10 million ($12.4 million).

NEW YORK (GenomeWeb News) – Molecular diagnostics company MDxHealth today said that revenues for the first quarter more than doubled year over year as its Pharmaco Diagnostic business grew 203 percent.

NanoString Launches Second Validation Study for PAM50
[This article has been updated from a previous version to correct details about NanoString's PAM50 test.]

NEW YORK (GenomeWeb News) – MDxHealth and Plus Diagnostics today announced a co-promotional deal covering MDxHealth's epigenetic test for prostate cancer in the US.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MDxHealth today reported that its fourth-quarter 2011 revenues increased 48 percent year over year, driven by its pharmaco diagnostic business.

FDA Greenlights Quest's PML Risk Test for Patients Prescribed Tysabri

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – MDxHealth today said that it has received CLIA certification for its laboratory in Irvine, Calif.

Pages

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.